23th April 2007 - Antitope Ltd. today announced a research agreement with Medtronic Inc. for the generation of a novel biologic. As part of the agreement, Antitope will apply its proprietary Composite Human AntibodyTM technology to produce a therapeutic antibody with a reduced risk of immunogenicity.
